Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Editorial Contact
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow SNMMI on Twitter
  • Visit SNMMI on Facebook

metastatic prostate cancer

  • You have access
    QUANTIFICATION OF METASTATIC PROSTATE CANCER WHOLE-BODY TUMOR BURDEN WITH FDG PET PARAMETERS AND ASSOCIATIONS WITH OVERALL SURVIVAL AFTER FIRST LINE ABIRATERONE OR ENZALUTAMIDE: A SINGLE- CENTER RETROSPECTIVE COHORT STUDY
    Andreas G. Wibmer, Michael J. Morris, Mithat Gonen, Junting Zheng, Hedvig Hricak, Steven M. Larson, Howard I. Scher and Hebert Alberto Vargas
    Journal of Nuclear Medicine January 8, 2021, jnumed.120.256602; DOI: https://doi.org/10.2967/jnumed.120.256602
  • You have access
    A Prospective Comparison of 18F-Sodium Fluoride PET/CT and PSMA-Targeted 18F-DCFBC PET/CT in Metastatic Prostate Cancer
    Stephanie A. Harmon, Ethan Bergvall, Esther Mena, Joanna H. Shih, Stephen Adler, Yolanda McKinney, Sherif Mehralivand, Deborah E. Citrin, Anna Couvillon, Ravi A. Madan, James L. Gulley, Ronnie C. Mease, Paula M. Jacobs, Martin G. Pomper, Baris Turkbey, Peter L. Choyke and M. Liza Lindenberg
    Journal of Nuclear Medicine November 1, 2018, 59 (11) 1665-1671; DOI: https://doi.org/10.2967/jnumed.117.207373
  • You have access
    A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition
    Aseem Anand, Michael J. Morris, Reza Kaboteh, Mariana Reza, Elin Trägårdh, Naofumi Matsunaga, Lars Edenbrandt, Anders Bjartell, Steven M. Larson and David Minarik
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1865-1871; DOI: https://doi.org/10.2967/jnumed.116.177030
  • You have access
    Repeatability of Quantitative 18F-NaF PET: A Multicenter Study
    Christie Lin, Tyler Bradshaw, Timothy Perk, Stephanie Harmon, Jens Eickhoff, Ngoneh Jallow, Peter L. Choyke, William L. Dahut, Steven Larson, John Laurence Humm, Scott Perlman, Andrea B. Apolo, Michael J. Morris, Glenn Liu and Robert Jeraj
    Journal of Nuclear Medicine December 1, 2016, 57 (12) 1872-1879; DOI: https://doi.org/10.2967/jnumed.116.177295
  • You have access
    Analytic Validation of the Automated Bone Scan Index as an Imaging Biomarker to Standardize Quantitative Changes in Bone Scans of Patients with Metastatic Prostate Cancer
    Aseem Anand, Michael J. Morris, Reza Kaboteh, Lena Båth, May Sadik, Peter Gjertsson, Milan Lomsky, Lars Edenbrandt, David Minarik and Anders Bjartell
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 41-45; DOI: https://doi.org/10.2967/jnumed.115.160085
  • You have access
    Comparison of Prostate-Specific Membrane Antigen–Based 18F-DCFBC PET/CT to Conventional Imaging Modalities for Detection of Hormone-Naïve and Castration-Resistant Metastatic Prostate Cancer
    Steven P. Rowe, Katarzyna J. Macura, Anthony Ciarallo, Esther Mena, Amanda Blackford, Rosa Nadal, Emmanuel S. Antonarakis, Mario A. Eisenberger, Michael A. Carducci, Ashley E. Ross, Philip W. Kantoff, Daniel P. Holt, Robert F. Dannals, Ronnie C. Mease, Martin G. Pomper and Steve Y. Cho
    Journal of Nuclear Medicine January 1, 2016, 57 (1) 46-53; DOI: https://doi.org/10.2967/jnumed.115.163782
SNMMI

© 2021 Journal of Nuclear Medicine

Powered by HighWire